Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
Basic Information
ID: ALA3785074
Journal: Eur J Med Chem
Title: Molecular modeling and snake venom phospholipase A2 inhibition by phenolic compounds: Structure-activity relationship.
Authors: Alam MI, Alam MA, Alam O, Nargotra A, Taneja SC, Koul S.
Abstract: In our earlier study, we have reported that a phenolic compound 2-hydroxy-4-methoxybenzaldehyde from Janakia arayalpatra root extract was active against Viper and Cobra envenomations. Based on the structure of this natural product, libraries of synthetic structurally variant phenolic compounds were studied through molecular docking on the venom protein. To validate the activity of eight selected compounds, we have tested them in in vivo and in vitro models. The compound 21 (2-hydroxy-3-methoxy benzaldehyde), 22 (2-hydroxy-4-methoxybenzaldehyde) and 35 (2-hydroxy-3-methoxybenzylalcohol) were found to be active against venom-induced pathophysiological changes. The compounds 20, 15 and 35 displayed maximum anti-hemorrhagic, anti-lethal and PLA2 inhibitory activity respectively. In terms of SAR, the presence of a formyl group in conjunction with a phenolic group was seen as a significant contributor towards increasing the antivenom activity. The above observations confirmed the anti-venom activity of the phenolic compounds which needs to be further investigated for the development of new anti-snake venom leads.
CiteXplore: 26986086
DOI: 10.1016/j.ejmech.2016.03.008
Patent ID: ┄